BioSpace News Archive

ColdQuanta Raises $32M in Series A Funding to Accelerate Development of Quantum Systems

ColdQuanta, the quantum atomics company, today announced it has raised $32M in Series A funding, with additional funding expected to close soon.

November 5, 2020
·
3 min read
Policy

Statement from the Chief Public Health Officer of Canada on November 5, 2020

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

November 5, 2020
·
3 min read
Biotech Beach

City of Hope Doctors Present New Research on Bone Marrow Transplants, Immunotherapy and Other Blood Cancer Treatments

Data will be presented at virtual American Society of Hematology (ASH) Annual Meeting Dec. 5 to 8

November 5, 2020
·
4 min read
BioForest

Neoleukin Therapeutics Announces Publication in Science of De Novo Protein Decoys that Block COVID-19 Infection In Vitro and Protect Animals In Vivo

- I ntranasal administration of NL-CVX1 protects hamsters from lethal SARS-CoV-2 infection – - Designed to r esist viral mutational escape b y mimicking the natural target of the s pike protein -

November 5, 2020
·
4 min read
Magnostics is Co-Developing and Launching a Viral RNA Extraction Kit for Medium Throughput Processing of COVID-19 Samples for Detection Using RT-PCR

Magnostics is leading a consortium of University and National Researchers to develop and launch Viral RNA Extraction Kits for detection of COVID-19.

November 5, 2020
·
3 min read
Genetown

Seven Bridges Announces Participation in NIH INCLUDE Project Data Coordinating Center

Collaboration across leading academic institutions and industry to create data coordinating center to advance understanding of Down syndrome and its co-occurring medical conditions

November 5, 2020
·
3 min read
Business

Calithera Biosciences Reports Third Quarter 2020 Financial Results and Recent Highlights

Calithera to Provide Corporate Update via Conference Call and Webcast at 2:00 p.m. PT on November 5, 2020

November 5, 2020
·
10 min read
Business

Collegium Reports Net Income of $11.3 Million in the Third Quarter of 2020

Strengthened Formulary Access for Xtampza® ER, Including Exclusive National Medicare Part D Win

November 5, 2020
·
13 min read
Pharm Country

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2020

In October, the Public Health Agency of Canada Announced its Intent to Purchase up to 33,300 Courses of Oral TPOXX®

November 5, 2020
·
11 min read
Biotech Bay

Nkarta Announces November & December 2020 Investor Conference Schedule

Nkarta, Inc., a clinical-stage biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced its participation at these upcoming investor conferences

November 5, 2020
·
1 min read